Global Over The Counter (OTC) Drugs Market Size, Status and Forecast 2024-2034
Global Over The Counter (OTC) Drugs Scope and Market Size
Over The Counter (OTC) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2016-2027)
2.2 Over The Counter (OTC) Drugs Growth Trends by Regions
2.2.1 Over The Counter (OTC) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Over The Counter (OTC) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Over The Counter (OTC) Drugs Industry Dynamic
2.3.1 Over The Counter (OTC) Drugs Market Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2016-2021)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2020
3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served
3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service
3.7 Date of Enter into Over The Counter (OTC) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2022-2027)
5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2016-2027)
6.2 North America Over The Counter (OTC) Drugs Market Size by Type
6.2.1 North America Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
6.2.2 North America Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
6.2.3 North America Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
6.3 North America Over The Counter (OTC) Drugs Market Size by Application
6.3.1 North America Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
6.3.2 North America Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
6.3.3 North America Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
6.4 North America Over The Counter (OTC) Drugs Market Size by Country
6.4.1 North America Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
6.4.2 North America Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2016-2027)
7.2 Europe Over The Counter (OTC) Drugs Market Size by Type
7.2.1 Europe Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Application
7.3.1 Europe Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
7.4 Europe Over The Counter (OTC) Drugs Market Size by Country
7.4.1 Europe Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type
8.2.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.4.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2016-2027)
9.2 Latin America Over The Counter (OTC) Drugs Market Size by Type
9.2.1 Latin America Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Application
9.3.1 Latin America Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country
9.4.1 Latin America Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type
10.2.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.4.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.2.5 Merck KGaA Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Details
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.6.5 Alkem Laboratories Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.9.5 Sun Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.10.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details